Hartford Investment Management Co. Sells 53 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Hartford Investment Management Co. reduced its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,509 shares of the biotechnology company’s stock after selling 53 shares during the quarter. Hartford Investment Management Co.’s holdings in Axon Enterprise were worth $1,802,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in AXON. Mather Group LLC. grew its position in Axon Enterprise by 3.7% in the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after purchasing an additional 27 shares in the last quarter. CWM LLC boosted its stake in shares of Axon Enterprise by 1.3% during the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock worth $1,141,000 after buying an additional 36 shares during the last quarter. SPC Financial Inc. grew its holdings in shares of Axon Enterprise by 2.2% in the 3rd quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock valued at $708,000 after acquiring an additional 38 shares in the last quarter. Dorsey Wright & Associates increased its position in shares of Axon Enterprise by 0.3% in the second quarter. Dorsey Wright & Associates now owns 14,053 shares of the biotechnology company’s stock valued at $4,135,000 after acquiring an additional 39 shares during the last quarter. Finally, Avantax Advisory Services Inc. raised its holdings in Axon Enterprise by 0.8% during the first quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock worth $1,659,000 after acquiring an additional 40 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $443.12 on Friday. The firm has a 50-day moving average price of $394.67 and a two-hundred day moving average price of $335.42. Axon Enterprise, Inc. has a 12-month low of $199.29 and a 12-month high of $455.17. The company has a market capitalization of $33.44 billion, a P/E ratio of 129.57, a P/E/G ratio of 12.05 and a beta of 0.94. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business had revenue of $504.00 million during the quarter, compared to analysts’ expectations of $478.35 million. During the same period in the previous year, the company posted $0.80 earnings per share. The firm’s revenue for the quarter was up 34.5% compared to the same quarter last year. Analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

Insider Transactions at Axon Enterprise

In related news, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the transaction, the director now owns 26,259 shares of the company’s stock, valued at $11,500,916.82. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, CFO Brittany Bagley sold 4,338 shares of Axon Enterprise stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total value of $1,643,885.10. Following the transaction, the chief financial officer now directly owns 98,825 shares of the company’s stock, valued at $37,449,733.75. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Michael Garnreiter sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total transaction of $437,980.00. Following the transaction, the director now owns 26,259 shares of the company’s stock, valued at approximately $11,500,916.82. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 371,172 shares of company stock valued at $137,000,162. 6.10% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research analysts have weighed in on AXON shares. Bank of America started coverage on Axon Enterprise in a research note on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price target for the company. Northland Securities lifted their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research report on Thursday, August 8th. Craig Hallum upped their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Jefferies Financial Group assumed coverage on Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target for the company. Finally, Needham & Company LLC raised their price objective on Axon Enterprise from $400.00 to $525.00 and gave the company a “buy” rating in a research report on Tuesday. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average price target of $382.85.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.